n= 10 per treatment group
N., Starchenko, A., Williams, R
This metabolic adaptation can be relevant in triple-negative breast cancers (those lacking ERs, PRs and HER2, which constitute approximately a quarter of breast tumours) that express xCT, which exhibit increased levels of ROS induced by decreased glutamate levels upon glutamine scarcity
Products are well packaged
Women who have used Depo-Provera and subsequently been diagnosed with brain tumors are filing lawsuits against Pfizer (the manufacturer), alleging that the company failed to adequately warn about the risks associated with the drug
Int J Mol Sci 22(6):3207 Wahlqvist ML, Lee M-S, Hsu C-C, Chuang S-Y, Lee J-T, Tsai H-N (2012) Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinsons disease occurring with Type 2 diabetes in a Taiwanese population cohort